A Novel Method for Pharmacosurveillance: Combining an Electronic Prescribing and Drug Management System and Administrative Database

药物监测新方法：电子处方和药物管理系统与管理数据库的结合

• 批准号: 171474
• 负责人: Tamblyn Robyn M
• 金额: $ 23.11万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-09-01 至 2012-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=171474&lang=en
• 关键词: Adverse Drug Reactions; Electronic Prescribing & Drug Managment System; Ineffective Treatments; Off-Label Indications; Patient Safety; Pharmacosurveillance

Medications are the most frequent causes of preventable adverse events including illness, and death. Drugs do not have complete information on safety and effectiveness at the time of market approval. Present-day adverse drug reaction monitoring systems re

药物是可预防不良事件（包括疾病和死亡）的最常见原因。药物在批准上市时没有关于安全性和有效性的完整信息。当前药品不良反应监测系统的发展